Digital Event: Next Generation Cell Therapies: Combined Analytics & Cryopreserved Starting Materials

Cell therapies are one of the most significant breakthroughs in modern medicine offering a novel approach to the treatment of critical, high mortality diseases by reprogramming human cells as a tool to combat disease. In recent years, several cell therapies have been successfully brought to market, but considerable challenges remain from process and product consistency to scalable manufacturing.

With a mix of live presentations and a panel discussion, this online meeting will explore the current advantages and ongoing industry challenges in the cell therapy field, as well as discussing optimized methodology with using cryopreserved leukapheresis materials for cell and gene therapies.

This is a unique opportunity for cell therapy experts to gain valuable lessons and the necessary tools to leverage process development strategies to improve the safety and ensure the quality of successful cell therapies and accelerate the clinical translation of your therapeutic pipeline!